Search for: "Boehringer Ingelheim Pharmaceuticals"
Results 61 - 80
of 252
Sort by Relevance
|
Sort by Date
5 Oct 2015, 3:15 pm
Similar Lawsuits Claims For Pradaxa Pradaxa, is another new-generation anticoagulant introduced by Boehringer Ingelheim in October 2010. [read post]
11 Sep 2015, 8:24 pm
Thousands of lawsuits were filed against Boehringer Ingelheim Pharmaceuticals, many by families who claimed their drug led to the wrongful death of loved ones. [read post]
25 Aug 2015, 10:38 am
Boehringer Ingelheim Pradaxa Clinical Trial Data not shared with FDA In July 2014, the BMJ reported that the Pradaxa’s Boehringer Ingelheim failed to provide the FDA with important clinical trial data. [read post]
21 Aug 2015, 11:35 am
Its diabetes drug Jardiance, co-marketed with Boehringer Ingelheim, is the first blood-sugar lowering pill ever to reduce the risk of heart attacks, strokes, and cardiovascular deaths in a big study, according to a press release issued this morning. [read post]
9 Jul 2015, 3:28 pm
Boehringer Ingelheim ultimately agreed to pay $650 million in Pradaxa settlements, with an average of about $150,000 per claim. [read post]
9 Jul 2015, 2:51 pm
AstraZeneca manufactures Farxiga and Xigduo, Jardiance and Glyxambi is made by Lilly and Boehringer Ingelheim. [read post]
8 Jul 2015, 8:31 am
Labs., Inc., 625 F.2d 1055 (3d Cir. 1980) (holding unique coloring of prescription drug capsule constituted protectable trade dress); Boehringer Ingelheim G.m.b.H. v. [read post]
10 Jun 2015, 11:51 am
This class of drugs consists of: Invokana — Janssen Pharmaceuticals — FDA Approval: 2013Invokamet — Janssen Pharmaceuticals — FDA Approval: 2014Farxiga — AstraZeneca Pharmaceuticals — FDA Approval: 2014Xigduo XR — AstraZeneca Pharmaceuticals — FDA Approval: 2014Jardiance — Boehringer Ingelheim Pharmaceuticals — FDA Approval: 2014Glyxambi — Boehringer… [read post]
20 Mar 2015, 8:00 am
Another blood thinning drug, Pradaxa, was manufactured by Boehringer Ingelheim Pharmaceuticals, which produced the blood-thinning drug. [read post]
17 Mar 2015, 3:09 am
Boehringer Ingelheim Pharmaceuticals, Inc.). [read post]
16 Mar 2015, 3:10 am
CJEU rules in telmisartan SPC disputeAfter his own earlier post on the CJEU’s decision in Case C‑577/13, Actavis Group PTC EHF, Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. [read post]
12 Mar 2015, 11:09 am
Today's the day that many pharmaceutical patent term extension-watchers have been waiting for with feelings of optimism or anxiety: the day on which the Court of Justice of the European Union (CJEU) delivered its ruling in Case C‑577/13, Actavis Group PTC EHF, Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. [read post]
9 Mar 2015, 2:38 pm
Litigation and Government Investigations at Boehringer Ingelheim Pharmaceuticals where she oversaw all U.S. litigation and government investigations. [read post]
25 Feb 2015, 3:17 am
When the German pharmaceutical company Boehringer Ingelheim settled with generic manufacturer Barr, the FTC opened an investigation looking at the settlement document and also subpoenaed further documents relating to the settlement. [read post]
16 Feb 2015, 3:44 am
Boehringer Ingelheim Pharmaceuticals, Inc., D. [read post]
23 Jan 2015, 12:59 pm
Boehringer Ingelheim—the manufacturer of Pradaxa—has paid close to $650 million to resolve the thousands of cases brought against it due to the drug’s harmful bleeding side effects. [read post]
21 Jan 2015, 3:02 pm
But as we’ve blogged, thousands of patients on Pradaxa, which was the first of the three to be approved by the FDA, have been harmed by uncontrolled bleeding, and its manufacturer, Boehringer Ingelheim, has been fined for covering up adverse outcomes in its research for the drug. [read post]
15 Jan 2015, 3:07 pm
Readers of this blog might recall that one drug maker, Boehringer Ingelheim, hid the uncontrolled bleeding it knew was happening during its trials of Pradaxa, a blood thinner. [read post]
8 Jan 2015, 7:03 am
… He said he no longer spoke on behalf of [blood thinner] Pradaxa because of what he characterized as public backlash against it, driven by a spate of lawsuits against its manufacturer, Boehringer-Ingelheim. [read post]
7 Jan 2015, 10:59 am
Although it’s a small company, that figure puts it in the company of major drug makers like Boehringer Ingelheim and Novo Nordisk, which market a lot of different products. [read post]
